The Indiana Hemophilia & Thrombosis Center (IHTC) is the only federally recognized comprehensive hemophilia treatment center in Indiana and one of the largest centers in the nation. The IHTC is a 501(c)3 nonprofit entity dedicated to providing the best, most comprehensive care to people in Indiana with bleeding disorders such as hemophilia, von Willebrand disease, other rare clotting factor deficiencies, and clotting conditions. IHTC is part of Innovative Hematology, Inc (IHI). Innovative Hematology treats blood disorders—from common to rare—every day. Innovative Hematology is a certified medical home recognized for excellence in comprehensive patient-centered health care. Our care providers treat sickle cell disease, thalassemia, HHT and nutritional anemias, as well as many other blood disorders. Our organization is both nationally and internationally distinguished as a Center of Excellence for its leadership in rare blood disorder patient care, education and research. **Note: All staff will be employed by IHTC through December 2024 and transition to employment through Innovative Hematology on January 1, 2025.